Friday File pt. 1: What’s Ernie Tremblay’s $7 Prostate Cancer Fighter?

Biotech Insider Alert pitches this as a "scientific breakthrough could help protect me, you, and 50 million American men…"

By Travis Johnson, Stock Gumshoe, August 10, 2018

We’re breaking the Friday File up into two parts today — starting with this look at a teaser from Ernie Tremblay that many of you have been asking about this week, a pitch for his Biotech Insider Alert ($1,950 a year) that includes, he says, a guarantee that you can request a refund if the stock he’s teasing doesn’t go up at least 10X in the next year.

Which could be a reflection of his confidence, or of Money Map’s analysis of how many folks are willing to actually call to request refunds months after a transaction.

The ad starts out with some really inflammatory language about a critical health crisis impacting all men over 50… giving you the sense that you’re just moments away from perishing in your sleep (no coincidence, “men over 50” is also the core demographic for investment newsletters):

“What I’m about to say will make your blood boil.

“It could also save your life.

“In fact, in the next few minutes, I’m going to expose the single biggest failure in modern medical history…

“A greed-fueled debacle that kills an American male every 18 minutes on average… every day, all year long.”

He goes on like that for a while, predicting doom and death, then moves on…

“Fortunately, there is good news.

“A breakthrough solution is at hand.

“A solution that could help protect 50 million American men – guys like you and me – from a gruesome fate.

“In fact, a major medical announcement is expected any day now, by September 30 at the latest.”

The “profit driven health disaster” that “kills one of us every 18 minutes” is, of course, prostate cancer… and he’s railing against the PSA test:

“Every year, 30 million American men take a prostate cancer test, known as the Prostate-Specific Antigen test… or PSA for short.

“The PSA test was FDA-approved in 1994, and it’s designed to help detect cancer.

“In fact, for the last 25 years, it’s been the first line of defense against prostate cancer….

“In theory, the PSA test is great.

“It’s designed to detect prostate cancer early, and give patients advanced notice so they can take necessary measures.

“Only one problem…

“The PSA Test Doesn’t Actually Detect Cancer!

“In fact, despite being the first line of defense against prostate cancer…

“It turns out the PSA test is nothing more than a profit-driven health disaster ...

Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? Log in)

Sign Up for a Premium Membership

To view the rest of this article (and to have full access to the rest of our articles), sign up.
Already a member, log in.

Become a member